Loss of TLE4 tumor suppressor cooperates with AML1-ETO in acute myeloid leukemia.
Loss of TLE4 activates Wnt signaling and pro-inflammatory genes.
TLE4 loss triggers leukemia cell proliferation and blocks differentiation.
TLE4 loss leads to chemotherapy resistance.
These pro-leukemic effects are blocked by COX inhibition.